Tianda Pharmaceuticals Limited (HKG:0455)

Tianda Pharmaceuticals Revenue

Tianda Pharmaceuticals had revenue of 164.22M HKD in the half year ending June 30, 2026, with 5.22% growth. This brings the company's revenue in the last twelve months to 350.53M, up 12.89% year-over-year. In the year 2025, Tianda Pharmaceuticals had annual revenue of 322.95M, down -2.12%.

• Revenue (ttm): 350.53M
• Revenue Growth: +12.89%
• P/S Ratio: 0.68
• Revenue / Employee: 611.75K
• Employees: 573
• Market Cap: 238.65M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	322.95M	-6.99M	-2.12%
Dec 31, 2024	329.94M	-202.15M	-37.99%
Dec 31, 2023	532.09M	-14.61M	-2.67%
Dec 31, 2022	546.69M	36.74M	7.20%
Mar 31, 2022	509.96M	35.62M	7.51%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 27, 2026

Data Sources Report a data error